PubMed · 8640183
Thalidomide responsive chronic pulmonary GVHD.
Abstract
A 29-year-old male underwent allogeneic bone marrow transplantation for progressive multiple myeloma. His post-transplant course was complicated by severe chronic pulmonary graft-versus-host disease (GVHD) resistant to cyclosporin A, corticosteroids and azathioprine. The introduction of thalidomide resulted in a dramatic improvement in his lung function which has been maintained even after cessation of thalidomide. He remains well 40 months after transplantation.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
C J Forsyth, P D Cremer, P Torzillo, H J Iland, G A Young. 1996. Thalidomide responsive chronic pulmonary GVHD.. https://pubmed.ncbi.nlm.nih.gov/8640183/
Cite the original work for its findings. Save a collection to share your selection of sources.